Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
VERV.US
id: 436, Created by Stan Vick Chase, Scout
Verve Therapeutics Inc
How it works?
- We find Attorney for the Case
- Attorney files case on behalf of Investors
- You get updates and receive payout in case of success
Would it cost me anything?
- No, you do not pay anything out of your pocket neither to us, nor to Attorney
- Attorneys get % fee in case of success
- Platform charges service fee from Attorneys
What are the chances for success?
Every Case is unique, but statistically, 47% of Cases end up with a settlement.
Please see below recent successful cases:
How it works?
- We find Attorney for the Case
- Attorney files case on behalf of Investors
- You get updates and receive payout in case of success
Would it cost me anything?
- No, you do not pay anything out of your pocket neither to us, nor to Attorney
- Attorneys get % fee in case of success
- Platform charges service fee from Attorneys
What are the chances for success?
Every Case is unique, but statistically, 47% of Cases end up with a settlement.
Please see below recent successful cases:
On November 7, 2022, Verve (VERV) announced that the FDA placed a hold on the company's Investigational New Drug (IND) application, halting a potential clinical trial for VERVE-101 to treat patients with heterozygous familial hypercholesterolemia (HeFH), a type of atherosclerotic cardiovasculorphan disease.
Verve had planned to use its gene-editing medicine to turn off the PCSK gene in the liver to reduce lipoprotein cholesterol (LDL-C), known to cause cardiovascular disease by building up in the arteries, leading to reduced blood flow or blockages and eventually, a heart attack or stroke.
On this news, VERV shares dropped more than 30% and the Company lost over $0.5 billion of its capitalization, seriously damaging shareholers.
Alleged Offence
Misleading Statements,
Failure to Disclose,
Negligence,
Breach of Fiduciary duty,
Omissions
Suspected Party
Directors,
Management,
Government Authority,
Service Provider
Security Type
Stocks
Trade Direction
Long
Shock Event Date
07 November 2022